HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Untch Selected Research

Pathologic Complete Response

11/2021Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness.
5/2021Update Breast Cancer 2021 Part 1 - Prevention and Early Stages.
4/2021Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial.
1/2021Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer.
12/2020Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis.
1/2020Evaluation of Pathologic Complete Response as a Surrogate for Long-Term Survival Outcomes in Triple-Negative Breast Cancer.
1/2020Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.
1/2019NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69-GeparSepto.
1/2019Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer.
3/2018Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Untch Research Topics

Disease

205Breast Neoplasms (Breast Cancer)
02/2022 - 07/2002
71Neoplasms (Cancer)
10/2022 - 01/2003
26Triple Negative Breast Neoplasms
10/2022 - 06/2014
25Pathologic Complete Response
11/2021 - 06/2009
7Neoplasm Metastasis (Metastasis)
10/2021 - 01/2010
6Disease Progression
01/2020 - 01/2003
6Infections
01/2020 - 06/2004
6Neutropenia
01/2020 - 06/2004
4Vomiting
01/2020 - 07/2002
4Febrile Neutropenia
01/2020 - 06/2004
4Nausea
01/2020 - 07/2002
4Exanthema (Rash)
01/2016 - 02/2012
4Cardiotoxicity
03/2013 - 06/2003
3Brain Neoplasms (Brain Tumor)
02/2022 - 03/2018
3Residual Neoplasm
01/2019 - 02/2009
3Carcinoma (Carcinomatosis)
10/2017 - 01/2003
3Diarrhea
07/2015 - 04/2010
3Thrombocytopenia (Thrombopenia)
06/2014 - 06/2009
3Anemia
07/2009 - 02/2008
2Amenorrhea
01/2021 - 01/2019
2Breast Diseases (Breast Disease)
06/2020 - 01/2020
2Inflammatory Breast Neoplasms
11/2019 - 10/2014
2Circulating Neoplastic Cells
09/2017 - 05/2010
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 07/2014
2Heart Failure
03/2016 - 03/2010
2Lobular Carcinoma
02/2014 - 06/2013
2Hand-Foot Syndrome
01/2012 - 04/2010

Drug/Important Bio-Agent (IBA)

49Trastuzumab (Herceptin)FDA Link
12/2021 - 06/2003
40Hormones (Hormone)IBA
01/2022 - 07/2002
29taxaneIBA
10/2021 - 08/2004
25human ERBB2 proteinIBA
01/2021 - 04/2010
24Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 01/2003
24Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 07/2002
24AnthracyclinesIBA
01/2021 - 02/2008
23Epirubicin (Ellence)FDA LinkGeneric
10/2022 - 08/2004
17Lapatinib (GW572016)FDA Link
01/2021 - 02/2006
12ErbB Receptors (EGF Receptor)IBA
12/2021 - 03/2010
11Estrogen ReceptorsIBA
10/2021 - 07/2002
10Carboplatin (JM8)FDA LinkGeneric
10/2022 - 06/2014
10Phenobarbital (Luminal)FDA Link
01/2022 - 10/2011
10Bevacizumab (Avastin)FDA Link
01/2020 - 01/2010
9Capecitabine (Xeloda)FDA Link
01/2022 - 10/2004
9Docetaxel (Taxotere)FDA Link
01/2020 - 04/2010
8Biomarkers (Surrogate Marker)IBA
05/2021 - 10/2011
6130-nm albumin-bound paclitaxelIBA
01/2022 - 04/2012
6pertuzumabIBA
06/2021 - 03/2013
6Pharmaceutical PreparationsIBA
02/2021 - 05/2006
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 06/2003
5TamoxifenFDA LinkGeneric
01/2020 - 02/2007
5Biological ProductsIBA
01/2020 - 02/2006
5Monoclonal AntibodiesIBA
01/2017 - 10/2005
4liposomal doxorubicin (Doxil)FDA Link
01/2022 - 01/2017
4Immunoconjugates (Immunoconjugate)IBA
05/2021 - 01/2019
4Immune Checkpoint InhibitorsIBA
05/2021 - 10/2016
4Messenger RNA (mRNA)IBA
01/2021 - 02/2013
3Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2022 - 01/2018
3Tyrosine Kinase InhibitorsIBA
12/2021 - 01/2009
3PlatinumIBA
11/2021 - 01/2003
3Ado-Trastuzumab EmtansineIBA
10/2020 - 01/2019
3MicroRNAs (MicroRNA)IBA
02/2020 - 08/2014
3Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 07/2002
3Cytotoxins (Cytolysins)IBA
01/2019 - 10/2004
3Epidermal Growth Factor (EGF)IBA
11/2017 - 02/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015 - 03/2004
3Aromatase InhibitorsIBA
04/2013 - 02/2007
3Taxoids (Taxanes)IBA
04/2012 - 01/2011
3epoetin betaIBA
11/2009 - 02/2008
2pembrolizumabIBA
10/2022 - 01/2020
2neratinibIBA
12/2021 - 06/2021
2veliparibIBA
11/2021 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2017
2Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 01/2018
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 06/2004
2SolventsIBA
01/2019 - 03/2016
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2016
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2017 - 10/2014
2Indicators and Reagents (Reagents)IBA
04/2017 - 01/2017
2Formaldehyde (Formol)FDA Link
10/2016 - 10/2014
2ParaffinIBA
10/2016 - 10/2014
2N,N'-bis(4-azidobenzoyl)cystineIBA
02/2016 - 02/2014
2exemestane (Aromasin)FDA Link
01/2016 - 12/2008
2AntibodiesIBA
03/2013 - 01/2009
2ErythropoietinFDA Link
07/2009 - 02/2008
2HematinicsIBA
07/2009 - 05/2009
2Phosphotransferases (Kinase)IBA
01/2009 - 02/2006
2Estrogens (Estrogen)FDA Link
11/2008 - 06/2007
2Acetates (Acetic Acid Esters)FDA Link
06/2007 - 07/2002
2Leuprolide (Lupron)FDA LinkGeneric
06/2007 - 07/2002

Therapy/Procedure

90Neoadjuvant Therapy
10/2022 - 04/2006
87Therapeutics
10/2022 - 01/2003
65Drug Therapy (Chemotherapy)
10/2022 - 07/2002
15Adjuvant Chemotherapy
01/2022 - 10/2005
6Radiotherapy
10/2021 - 07/2014
4Precision Medicine
06/2020 - 03/2018
4Mastectomy (Mammectomy)
11/2019 - 08/2015
4Aftercare (After-Treatment)
11/2018 - 10/2011
4Segmental Mastectomy (Lumpectomy)
10/2017 - 10/2014
3Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 10/2004
2Operative Surgical Procedures
10/2021 - 02/2005
2Erythrocyte Transfusion
07/2009 - 05/2009